Intervacc AB has appointed Anna-Carin Lagerlöf as Sales and Marketing Director. In this newly established role, Lagerlöf will focus on driving sales growth, particularly for Strangvac, the company's vaccine against strangles in horses. She joins Intervacc from IDEXX Laboratories, where she was Country Manager for the Nordics. Lagerlöf will assume her new position in November and join the executive management team.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intervacc AB published the original content used to generate this news brief via Cision (Ref. ID: 20250924:BIT:2526:0) on September 25, 2025, and is solely responsible for the information contained therein.